- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the whole blood pharmacokinetics and comparative bioavailability (AUC0-∞, Cmax, Tmax and apparent t1/2) of 2 new granule formulations of ridaforolimus compared to the provisional market 10 mg ECT in healthy subjects.
Critère d'inclusion
- Sarcoma